
NEJM This Week — August 21, 2025
NEJM This Week
00:00
Evaluating Adjuvant Therapies and AI in Medical Education
This chapter explores a phase 3 trial on the effectiveness of adjuvant simiplumab for high-risk skin cancer patients, emphasizing its influence on disease-free survival. It also examines educational strategies for effectively incorporating artificial intelligence in clinical supervision, discussing both its transformative potential and the inherent risks.
Transcript
Play full episode